Cost-effectiveness analysis of FOLFOX4 and sorafenib for...

Cost Effectiveness and Resource Allocation 2018 / 12 Vol. 16; Iss. 1

Cost-effectiveness analysis of FOLFOX4 and sorafenib for the treatment of advanced hepatocellular carcinoma in China

Qin, Shukui, Kruger, Eliza, Tan, Seng Chuen, Cheng, Shuqun, Wang, Nanya, Liang, Jun
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
16
Language:
english
Journal:
Cost Effectiveness and Resource Allocation
DOI:
10.1186/s12962-018-0112-0
Date:
December, 2018
File:
PDF, 1.09 MB
english, 2018
Conversion to is in progress
Conversion to is failed